Publication | Closed Access

Novel α-Aminophosphonates of imatinib Intermediate: Synthesis, anticancer Activity, human Abl tyrosine kinase Inhibition, ADME and toxicity prediction

Molecular PharmacologyMedicinal ChemistryMedicinePharmacologyAnti-cancer AgentImatinib IntermediateToxicity PredictionOncologyRadiation OncologyPharmaceutical ChemistryNovel α-AminophosphonatesCancer ResearchDrug Discovery